Publications

A phase I trial of erlotinib, gemcitabine and radiation for patients with locally advanced, unresectable pancreatic cancer

JS Kortmansky, EM O’Reilly, BD Minsky, SA Puleio, J Winkelmann, ...

A phase II study of intravenous exatecan administered daily for 5 days, every 3 weeks to patients with biliary tract cancers

GK Abou-Alfa, EK Rowinsky, YZ Patt, GK Schwartz, DP Kelsen, S Sharma, ...

Biliary Tract Cancer

GD Leonard, EM O'Reilly, CJ Allegra

Biliary tract cancers: current concepts and controversies

GD Leonard, EM O’Reilly

History of Clinical Trials

JA Konner, EM O'Reilly

Phase I and Pharmacokinetic Study of LY293111, an Orally Bioavailable LTB4 Receptor Antagonist, in Patients With Advanced Solid Tumors

GK Schwartz, A Weitzman, E O'Reilly, L Brail, DP de Alwis, A Cleverly, ...

Phase I trial of the cyclin-dependent kinase inhibitor and protein kinase C inhibitor 7-hydroxystaurosporine in combination with Fluorouracil in patients with advanced solid tumors

J Kortmansky, MA Shah, A Kaubisch, A Weyerbacher, S Yi, W Tong, ...

Visceral Thromboses in Pancreas Adenocarcinoma: A Systematic Review

A Mier, MDS Antonio DeRosa, MD Michael Raj, R Do, EM O’Reilly

A phase I dose finding study of weekly, sequential docetaxel (Doc) followed by flavopiridol (F) in patients with advanced solid tumors

D Rathkopf, M Fornier, M Shah, J Kortmansky, E O'Reilly, A King, ...

A randomized phase III trial of DX-8951f (exatecan mesylate; DX) and gemcitabine (GEM) vs. gemcitabine alone in advanced pancreatic cancer (APC)

EM O'Reilly, GK Abou-Alfa, R Letourneau, WG Harker, M Modiano, ...

A randomized phase III trial of OX-8951f (Exatecan Mesylate; DX) and Gemcitabine (GEM) vs. Gemcitabine alone in advanced pancreatic cancer (APC).

EM O'Reilly, GK Abou-Alfa, R Letourneau, WG Harker, M Modiano, ...

Management of hyperglycemia in patients with metastatic pancreatic cancer receiving UCN-01 and fluorouracil

JS Kortmansky, N Sauter, E O'Reilly, M Shah, GK Abou-Alfa, ...

Phase I dose-finding study of weekly (W) docetaxel (T) followed by flavopiridol (F) for patients with metastatic solid tumors

MN Fornier, D Rathkopi, M Shah, C Hudis, E O'Reilly, J Kormansky, ...

Gemcitabine-induced peripheral edema: report on 15 cases and review of the literature

CG Azzoli, VA Miller, KK Ng, LM Krug, ML Hensley, EM O’Reilly, ...

Mutations in a gene encoding a novel protein containing a phosphotyrosine-binding domain cause type 2 cerebral cavernous malformations

CL Liquori, MJ Berg, AM Siegel, E Huang, JS Zawistowski, TP Stoffer, ...

Phase I trial of escalating-dose irinotecan given weekly with cisplatin and concurrent radiotherapy in locally advanced esophageal cancer

DH Ilson, M Bains, DP Kelsen, E O’Reilly, M Karpeh, D Coit, V Rusch, ...

Phase II trial of 96-hour paclitaxel in previously treated patients with advanced esophageal cancer

SE Anderson, EM O'Reilly, DP Kelsen, DH Ilson

Reduction in the minimal candidate region of cerebral cavernous malformations type 3 (CCM3) on chromosome 3q26. 31-27.3.

CL Liquori, V Maglione, F Balogun, M Cannella, E Huang, L Hughes, ...

A phase I/II study of DX-8951f and gemcitabine in advanced solid tumour malignancies

G Abou-Alfa, R Lenzi, S Mani, G Schwartz, R Maki, D Kelsen, A Levin, ...

A phase II trial of farnesyl protein transferase inhibitor SCH 66336, given by twice-daily oral administration, in patients with metastatic colorectal cancer refractory to 5 …

S Sharma, N Kemeny, DP Kelsen, D Ilson, E O’reilly, S Zaknoen, C Baum, ...

Cancers of the Gallbladder and Biliary Ducts

EM O'Reilly

Cancers of the Gallbladder and Biliary Ducts-The Article Reviewed

EM O'Reilly

Pancreatic cancer: epidemiology, genetics, and approaches to screening.

J Konner, E O'Reilly

Phase I and pharmacokinetic study of LY293111, an orally available small molecule known to be an LTB4 receptor antagonist, 5-lipoxygenase inhibitor and peroxisome proliferator …

DR Budman, GK Schwartz, S Endres, M Welch, E O'Reilly, B Barile-Thiem, ...

Phase I study of the cyclin-dependent kinase inhibitor flavopiridol in combination with paclitaxel in patients with advanced solid tumors

GK Schwartz, E O’Reilly, D Ilson, L Saltz, S Sharma, W Tong, P Maslak, ...

Phase I trial of weekly cisplatin, irinotecan, and radiation in esophageal cancer: A well tolerated regimen

D Ilson, M Bains, M Karpeh, E O'Reilly, D Kelsen, B Minsky

Radical resection of rectal cancer primary tumor provides effective local therapy in patients with stage IV disease

GM Nash, LB Saltz, NE Kemeny, B Minsky, S Sharma, GK Schwartz, ...

Radical surgery as local therapy for stage IV rectal cancer: treatment results

GM Nash, L Saltz, S Sharma, N Kemeny, G Schwartz, D Ilson, E O'Reilly, ...

Should patients with locally advanced pancreatic adenocarcinoma undergo laparoscopic staging prior to initiation of chemoradiation?

M Shoup, MF Brennan, E O'Reilly, C Winston, R McMahon, D Bassman, ...

Vaccine therapy for pancreatic cancer

EM O’Reilly

A phase II study of irinotecan in patients with advanced hepatocellular carcinoma

EM O'Reilly, KE Stuart, PM Sanz‐Altamira, GK Schwartz, CM Steger, ...

A phase II trial of irinotecan (CPT-11) for unresectable biliary tree carcinoma

PM Sanz-Altamira, E O’Reilly, KE Stuart, L Raeburn, C Steger, ...

Chemotherapy for Resectable and Advanced Pancreatic Cancer-The Article Reviewed

EM O'Reilly, DP Kelsen

Cisplatin and irinotecan in upper gastrointestinal malignancies.

EM O'Reilly, DH Ilson

Phase I study of topoisomerase I inhibitor exatecan mesylate (DX-8951f) given as weekly 24-hour infusions three of every four weeks

S Sharma, N Kemeny, GK Schwartz, D Kelsen, E O’Reilly, D Ilson, J Coyle, ...

Phase II study of the cyclin-dependent kinase inhibitor flavopiridol administered to patients with advanced gastric carcinoma

GK Schwartz, D Ilson, L Saltz, E O’Reilly, W Tong, P Maslak, J Werner, ...

Surgical debulking and intraperitoneal chemotherapy for established peritoneal metastases from colon and appendix cancer

AT Culliford IV, AD Brooks, S Sharma, LB Saltz, GK Schwartz, EM O’Reilly, ...

A phase II study of exatecan mesylate (DX-8951f) in advanced pancreatic cancer.

E O'Reilly, L Hammond, R Donehower, G Schwartz, J Kelvin, S Aird, ...

Memorial Sloan-Kettering Cancer Center Experience with Intraperitoneal Chemotherapy for Gastric Cancer

EM O’Reilly, DP Kelsen

Phase I trial of cisplatin and escalating doses of irinotecan given weekly with concurrent radiation in esophageal cancer.

D Ilson, S Anderson, M Bains, E O'Reilly, D Kelsen, M Karpeh, L Saltz, ...

Three-dimensional CT venography of the portal venous system in patients with pancreatic adenocarcinoma using multidetector CT scanning

CB Winston, KC Conlon, JB Teitcher, EM O'Reilly, MF Brennan

5‐Fluorouracil‐induced small bowel toxicity in patients with colorectal carcinoma

F Fata, IG Ron, N Kemeny, E O'Reilly, D Klimstra, DP Kelsen

A phase II trial of interferon alpha-2a and carboplatin in patients with advanced malignant mesothelioma

EM O'Reilly, DH Ilson, LB Saltz, R Heelan, L Martin, DP Kelsen

Paclitaxel in the treatment of patients with angiosarcoma of the scalp or face

F Fata, E O'Reilly, D Ilson, D Pfister, D Leffel, DP Kelsen, GK Schwartz, ...

Phase I trial of sequential paclitaxel and cisplatin in combination with the cyclin dependent kinase inhibitor flavopiridol (flavo) in patients with advanced solid tumors.

GK Schwartz, A Kaubisch, L Saltz, D Ilson, E O'Reilly, J Barazzuol, ...

Phase II trial of weekly irinotecan plus cisplatin in advanced esophageal cancer

DH Ilson, L Saltz, P Enzinger, Y Huang, A Kornblith, M Gollub, E O'Reilly, ...

A phase II trial of cisplatin and irinotecan in patients with advanced esophageal cancer

P Enzinger, DH Ilson, LB Saltz, EM O'Reilly, MJ Gollub, JA DeGroff, ...

A phase II trial of irinotecan (CPT-11) in patients with advanced hepatocellular carcinomas

E O'Reilly, K Stuart, N Kemeny, C Steger, L Raeburn, P Sanz-Altamira, ...

Flavopiridol enhances the biological effects of paclitaxel: a phase I trial in patients with advanced solid tumors

G Schwartz, JL Werner, P Maslak, L Saltz, E O'Reilly, DP Kelsen, D Inzeo, ...

Irinotecan and cisplatin in upper gastrointestinal malignancies.

PC Enzinger, DH Ilson, LB Saltz, EM O'Reilly, DP Kelsen